Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -284.92% is 14% above its 4-year average of -330.54%, near the high end of its 4-year range (-6809.59%–-70.23%).
61.30% above its 12-month average of -736.26%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -2166.91%.
EBITDA MARGIN
-284.92%
EBITDA MARGIN AVG TTM
-736.26%
EBITDA MARGIN AVG 3Y
-283.01%
EBITDA MARGIN AVG 5Y
-330.54%
EBITDA MARGIN AVG 10Y
-245.34%
EBITDA MARGIN AVG 15Y
-324.53%
EBITDA MARGIN AVG 20Y
-327.74%
CURRENT VS TTM AVG
+61.30%
CURRENT VS 3Y AVG
-0.68%
CURRENT VS 5Y AVG
+13.80%
CURRENT VS 10Y AVG
-16.13%
CURRENT VS 15Y AVG
+12.21%
CURRENT VS 20Y AVG
+13.06%
Cerenome, Inc.
Market Cap
$11.05M
EBITDA Margin
-284.92%
TTM Avg
-736.26%
3Y Avg
-283.01%
5Y Avg
-330.54%
Market Cap
$11.06M
EBITDA Margin
-10625.29%
TTM Avg
-6424.40%
3Y Avg
-6424.40%
5Y Avg
-6424.40%
Market Cap
$11.12M
EBITDA Margin
28.31%
TTM Avg
28.31%
3Y Avg
28.31%
5Y Avg
-18969.31%
Market Cap
$11.23M
EBITDA Margin
-5625.93%
TTM Avg
-8506.17%
3Y Avg
-6687.48%
5Y Avg
-5181.84%
Market Cap
$10.82M
EBITDA Margin
-133689.80%
TTM Avg
-133689.80%
3Y Avg
-133689.80%
5Y Avg
-133689.80%
Market Cap
$10.65M
EBITDA Margin
-75.15%
TTM Avg
-68.19%
3Y Avg
-159.10%
5Y Avg
-185.14%
Market Cap
$10.59M
EBITDA Margin
-2404.23%
TTM Avg
-2020.23%
3Y Avg
-5031.76%
5Y Avg
-7490.37%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cerenome, Inc. (CNSY) | $11.05M | -284.92% | -736.26% | -283.01% | -330.54% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.06M | -10625.29% | -6424.40% | -6424.40% | -6424.40% |
| BioVie Inc. (BIVI)vs › | $11.08M | N/A | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.12M | 28.31% | 28.31% | 28.31% | -18969.31% |
| VistaGen Therapeutics, Inc. (VTGN)vs › | $11.23M | -5625.93% | -8506.17% | -6687.48% | -5181.84% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.27M | N/A | N/A | N/A | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.82M | -133689.80% | -133689.80% | -133689.80% | -133689.80% |
| Lifeward Ltd. (LFWD)vs › | $10.65M | -75.15% | -68.19% | -159.10% | -185.14% |
| Pluri Inc. (PLUR)vs › | $10.59M | -2404.23% | -2020.23% | -5031.76% | -7490.37% |
| Senti Biosciences, Inc. (SNTI)vs › | $10.59M | -273136.36% | -273136.36% | -93106.62% | -57343.52% |
Gross Margin
89.6%
EBITDA Margin
-284.9%
Operating Margin
-293.5%
Net Margin
-620.7%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -2166.91% |
| 2026-03-31 | -681.91% |
| 2025-12-31 | -415.87% |
| 2025-09-30 | -314.67% |
| 2025-06-30 | -101.94% |
| 2025-03-31 | -316.81% |
| 2024-12-31 | -259.77% |
| 2024-09-30 | -244.99% |
| 2024-06-30 | -273.26% |
| 2024-03-31 | -185.63% |
| 2023-12-31 | -289.03% |
| 2023-09-30 | -247.02% |
| 2023-06-30 | -70.23% |
| 2023-03-31 | -895.85% |
| 2022-12-31 | -3500.00% |
| 2022-09-30 | -6809.59% |
| 2020-06-30 | -1220.54% |
| 2020-03-31 | -1988.98% |
| 2019-12-31 | -176.35% |
| 2019-09-30 | 59.55% |
| 2019-06-30 | -591.06% |
| 2019-03-31 | -177.64% |
| 2018-12-31 | -154.38% |
| 2018-09-30 | -132.39% |
| 2018-06-30 | -162.80% |
| 2018-03-31 | -233.92% |
| 2017-12-31 | -202.68% |
| 2017-09-30 | -213.03% |
| 2017-06-30 | -331.40% |
| 2017-03-31 | -415.60% |
| 2016-12-31 | -105.72% |
| 2016-09-30 | -175.36% |
| 2016-06-30 | -210.30% |
| 2016-03-31 | -164.70% |
| 2015-12-31 | -51.72% |
| 2015-09-30 | 90.75% |
| 2015-06-30 | 175.93% |
| 2015-03-31 | -885.93% |
| 2014-12-31 | -107.80% |
| 2014-09-30 | -698.91% |
| 2014-06-30 | -813.40% |
| 2014-03-31 | -654.60% |
| 2013-12-31 | -250.17% |
| 2013-09-30 | -293.32% |
| 2013-06-30 | -374.37% |
| 2013-03-31 | -176.18% |
| 2012-12-31 | -56.55% |
| 2012-09-30 | -712.16% |
| 2012-06-30 | -153.72% |
| 2012-03-31 | -548.85% |
| 2011-12-31 | -695.64% |
| 2011-09-30 | -400.79% |
| 2011-06-30 | -389.18% |
| 2011-03-31 | -425.45% |
| 2010-12-31 | -321.53% |
| 2010-09-30 | -591.67% |
| 2010-06-30 | -226.98% |
| 2010-03-31 | -40.89% |
| 2009-12-31 | -302.16% |
| 2009-09-30 | -434.05% |
| 2009-06-30 | 1.18% |
| 2009-03-31 | -273.85% |
| 2008-12-31 | 3316.86% |
| 2008-09-30 | -276.81% |
| 2008-06-30 | -568.87% |
| 2008-03-31 | -5186.93% |
| 2007-12-31 | -43441.67% |
| 2007-09-30 | -154.94% |
| 2007-06-30 | -1107.42% |
| 2007-03-31 | -3003.93% |
| 2006-12-31 | -22.03% |
| 2006-09-30 | -6306.02% |
| 2006-06-30 | -2105.30% |
| 2006-03-31 | -1400.80% |
| 2005-12-31 | -1359.56% |
| 2005-09-30 | -470.29% |
| 2005-06-30 | -332.39% |
| 2005-03-31 | -233.79% |
| 2004-09-30 | -221.31% |
| 2004-06-30 | -220.00% |
| 2004-03-31 | -130.53% |
| 2003-12-31 | -16.03% |
| 2003-09-30 | -35.22% |
| 2003-06-30 | -60.01% |
| 2003-03-31 | -156.09% |
| 2002-12-31 | -157.11% |
| 2002-09-30 | -76.92% |
